Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery
Status:
Terminated
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This was a Phase 2a prospective, single center, randomized, double-blind, placebo-controlled
study designed to assess the efficacy, pharmacokinetics, safety and tolerability of IV
elamipretide for reduction of reperfusion injury in subjects with Atherosclerotic Renal
Artery Stenosis (ARAS), who are undergoing percutaneous transluminal angioplasty of the renal
artery (PTRA).